Estimating measures of interaction on an additive scale for preventive exposures
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Measures of interaction on an additive scale (relative excess risk due to interaction [RERI], attributable proportion [AP], synergy index [S]), were developed for risk factors rather than preventive factors. It has been suggested that preventive factors should be recoded to risk factors before calculating these measures. We aimed to show that these measures are problematic with preventive factors prior to recoding, and to clarify the recoding method to be used to circumvent these problems. Recoding of preventive factors should be done such that the stratum with the lowest risk becomes the reference category when both factors are considered jointly (rather than one at a time). We used data from a case-control study on the interaction between ACE inhibitors and the ACE gene on incident diabetes. Use of ACE inhibitors was a preventive factor and DD ACE genotype was a risk factor. Before recoding, the RERI, AP and S showed inconsistent results (RERI = 0.26 [95%CI: -0.30; 0.82], AP = 0.30 [95%CI: -0.28; 0.88], S = 0.35 [95%CI: 0.02; 7.38]), with the first two measures suggesting positive interaction and the third negative interaction. After recoding the use of ACE inhibitors, they showed consistent results (RERI = -0.37 [95%CI: -1.23; 0.49], AP = -0.29 [95%CI: -0.98; 0.40], S = 0.43 [95%CI: 0.07; 2.60]), all indicating negative interaction. Preventive factors should not be used to calculate measures of interaction on an additive scale without recoding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, this measure should only be used if the doubly unexposed group is the one with the lowest absolute risk.30”
From Recommendations for presenting analyses of effect modification and interaction (2012) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calculating measures of biological interaction
Andersson, T., Alfredsson, L., Källberg, H., Zdravkovic, S., & Ahlbom, A. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-7835-x · Cited by 1,498
Confidence interval estimation of interaction
Hosmer, D. W., & Lemeshow, S. (1992) · Epidemiology · doi:10.1097/00001648-199209000-00012 · Cited by 1,239 · cited 1×
“Second, we calculated the three measures of interaction on an additive scale (RERI, AP, and S) and their 95% confidence intervals using the delta method [9], assuming that the odds ratios calculated in the example dataset approximated relative risks.”
MethodROTHMAN, K. J., GREENLAND, S., & WALKER, A. M. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113015 · Cited by 859 · cited 1×
“A number of epidemiologists have argued that biologic interaction should be assessed on an additive scale rather than a multiplicative scale [1–6].”
BackgroundKnol, M. J., van der Tweel, I., Grobbee, D. E., Numans, M. E., & Geerlings, M. I. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym157 · Cited by 444 · cited 1×
“Moreover, methods to calculate confidence intervals around these measures have been developed [8–10], and methods to quantify interaction on an additive scale in the case of continuous determinants have been presented [11].”
MethodSelf-citationTHE ESTIMATION OF SYNERGY OR ANTAGONISM1
ROTHMAN, K. J. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112252 · Cited by 333
On the estimation of additive interaction by use of the four-by-two table and beyond
Zou, G. Y. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn104 · Cited by 274
Confidence intervals for measures of interaction
Assmann, S. F., Hosmer, D. W., Lemeshow, S., & Mundt, K. A. (1996) · Epidemiology · doi:10.1097/00001648-199605000-00012 · Cited by 262
Estimation of the relative excess risk due to interaction and associated confidence bounds
Richardson, D. B., & Kaufman, J. S. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwn411 · Cited by 240
The effect of joint exposures: examining the presence of interaction
de Mutsert, R., Jager, K. J., Zoccali, C., & Dekker, F. W. (2009) · Kidney International · doi:10.1038/ki.2008.645 · Cited by 222
Obesity, Smoking, and Physical Inactivity as Risk Factors for CKD: Are Men More Vulnerable?
Hallan, S., de Mutsert, R., Carlsen, S., Dekker, F. W., Aasarød, K., & Holmen, J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.11.027 · Cited by 208
The identification of synergism in the sufficient-component-cause framework
VanderWeele, T. J., & Robins, J. M. (2007) · Epidemiology · doi:10.1097/01.ede.0000260218.66432.88 · Cited by 183
Self-citationHow to evaluate interaction between causes: a review of practices in cardiovascular epidemiology
HALLQVIST, J., AHLBOM, A., DIDERICHSEN, F., & REUTERWALL, C. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.431782000.x · Cited by 135
Marenholz, I., Kerscher, T., Bauerfeind, A., Esparza-Gordillo, J., Nickel, R., Keil, T. O. P., Lau, S., Rohde, K., Wahn, U., & Lee, Y. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.01.051 · Cited by 134
VanderWeele, T. J., & Knol, M. J. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr009 · Cited by 46
Self-citationLow LDL Cholesterol, Albuminuria, and Statins for the Risk of Cancer in Type 2 Diabetes
Yang, X., So, W. Y., Ronald, C. W., Ko, G. T. C., Kong, A. P. S., Zhao, H., Luk, A. O. Y., Lam, C. W. K., Ho, C. S., Tong, P. C. Y., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0725 · Cited by 43
Bozkurt, Ö., Verschuren, W. M. M., Wijer, B. M. A. V. W.-D., Knol, M. J., de Boer, A., Grobbee, D. E., Geerlings, M. I., Heerdink, E. R., & Klungel, O. H. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.62 · Cited by 19
Self-citationYang, X., Ronald, C. W., So, W. Y., Ko, G. T. C., Kong, A. P. S., Zhao, H., Xu, G., Tong, P. C. Y., & Chan, J. C. N. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.012 · Cited by 17
Rothman, K. J., Huybrechts, K. F., & Murray, E. J. (2024) · doi:10.1093/oso/9780197751541.001.0001 · Cited by 12
Research works printed but not linked: 1
- Rothman KJ. Measuring interactions. Epidemiology: an introduction. Oxford: University Press; 2002. p. 168–80.
Cited by
Recommendations for presenting analyses of effect modification and interaction
Knol, M. J., & VanderWeele, T. J. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr218 · Cited by 1,494
Self-citationVanderWeele, T. J., & Knol, M. J. (2014) · Epidemiologic Methods · doi:10.1515/em-2013-0005 · Cited by 1,127
Self-citationLapi, F., Azoulay, L., Yin, H., Nessim, S. J., & Suissa, S. (2013) · BMJ · doi:10.1136/bmj.e8525 · Cited by 393
Association of Religious Service Attendance With Mortality Among Women
Li, S., Stampfer, M. J., Williams, D. R., & VanderWeele, T. J. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1615 · Cited by 367
Self-citationThe Rotterdam Study: 2014 objectives and design update
Hofman, A., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Arfan Ikram, M., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., Stricker, B. H. C., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9866-z · Cited by 330
Metadata
- Authors
- Knol, M. J., VanderWeele, T. J., Groenwold, R. H. H., Klungel, O. H., Rovers, M. M., & Grobbee, D. E.
- Affiliations
- University Medical Center Utrecht (NL)
- Harvard University (US)
- Utrecht University (NL)
- Corresponding author
- Knol, Mirjam J.
- ORCID
- Venue
- European Journal of Epidemiology
- Published
- 2011-02-23
- Volume
- 26
- Issue
- 6
- Pages
- 433-438
- ISSN
- 0393-2990 (ISSN-L)
- 1573-7284
- PMC
- PMC3115067
- OpenAlex
- W2130460526
- Cited by
- 776
- References
- 18
- Citations by year
- 2026: 82 · 2025: 117 · 2024: 113 · 2023: 78 · 2022: 65 · 2021: 55 · 2020: 53 · 2019: 40 · 2018: 36 · 2017: 29 · 2016: 26 · 2015: 19 · 2014: 28 · 2013: 18 · 2012: 12
- FWCI
- 17.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Journal of Epidemiology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Funders
- Top Institute Pharma (T6-202)
- National Institutes of Health (ES017876)
- National Institute of Environmental Health Sciences (R01ES017876)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- interaction measure, relative excess risk due to interaction, attributable proportion, synergy index, preventive factors, risk factors, reference category, ACE inhibitors, ACE gene, diabetes mellitus, gene-environment interaction
- MeSH terms
- Data Interpretation, Statistical, Humans, Primary Prevention, Risk Factors, Epidemiologic Research Design, Causality, Case-Control Studies, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.